Corbus Pharma (CRBP) Misses Q2 EPS by 55c

Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($1.81), $0.55 worse than the analyst estimate of ($1.26).

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Citi cuts Lowe's price target to $260, keeps Buy rating
• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c